CAR-NK cells derived from umbilical cord blood
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-NK cells derived from umbilical cord blood, covering 2024-03-25 to 2024-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies [Phase 1, Phase 2]